| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 14, 2026, Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of Ocular Therapeutix, Inc. (the “Company”), notified the Company of his resignation from the Company, effective October 16, 2026, to become the Chief Executive O... |
| 13 Oct 2026 |
Form 4: Anderman Todd, Chief Legal Officer
Sold 11,984 shares ($87.4K) |
| 08 Oct 2026 | 144 |
| 06 Oct 2026 |
Form 4: Kaiser Peter, Chief Development Officer
Sold 9,990 shares ($70.4K) |
| 06 Oct 2026 |
Form 4: Heier Jeffrey S., Chief Scientific Officer
Sold 10,869 shares ($76.6K) |
| 02 Oct 2026 | 144 |
| 02 Oct 2026 | 144 |
| 02 Sep 2026 |
Form 4: Notman Donald, Chief Operating Officer
Sold 1,099 shares ($11.3K) |
| 31 Aug 2026 | 144 |
| 26 Aug 2026 |
Form 4: Kaiser Peter, Chief Development Officer
Sold 3,035 shares ($32.7K) |
| 26 Aug 2026 |
Form 4: Nayak Sanjay, Chief Strategy Officer
Sold 1,897 shares ($20.4K) |
| 26 Aug 2026 |
Form 4: Heier Jeffrey S., Chief Scientific Officer
Sold 3,296 shares ($35.5K) |
| 26 Aug 2026 |
Form 4: Dugel Pravin, Director
Sold 21,649 shares ($233K) · Gave 50,092 shares as a gift · Acquired 50,092 shares (Gift) |
| 24 Aug 2026 | 144 |
| 24 Aug 2026 | 144 |
| 24 Aug 2026 | 144 |
| 24 Aug 2026 | 144 |
| 03 Aug 2026 | FORM S-8 |
| 03 Aug 2026 | 10-Q |
| 03 Aug 2026 | 8-K: Results of Operations and Financial Condition |
Loading...
